<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180626040240N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-08-01</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the Maternal Hemodynamic between Epidural Analgesia Delivery and Combined Spinal-Epidural Analgesia Delivery</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the Maternal Hemodynamic between Epidural Analgesia Delivery and Combined Spinal-Epidural Analgesia Delivery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-06-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>100</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/32242</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Blinding description: The pregnant gives consent to the Analgesia  while she is blind to its type.
Trained anesthetize technician and an accoucheuse who are blind to the analgesia type monitor and record the maternal hemodynamic.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Analgesia for normal vaginal delivery.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Epidural analgesia                                                           The neuroaxial  block is performed with epidural needle number 18 G . First, for the  test dose: 3 ml of lidocaine 1.5%, 50 μg of fentanyl and 2.5 mg of bupivacaine  is used. Then as a preservative dose 6 cc / h from this solution is injected through the catheter. Intervention 2: Intervention group: combined spinal-epidural analgesia                            First with  a spinal needle 25G, the spinal block with 1.5ml of the same solution is performed and then the epidural block will be performed using the same method of epidural group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
We will act according to the laws of the Ministry of Health and Medical Education and Tabriz University of Medical Sciences

When:
We will act according to the laws of the Ministry of Health and Medical Education and Tabriz University of Medical Sciences

To whom:
We will act according to the laws of the Ministry of Health and Medical Education and Tabriz University of Medical Sciences

Conditions:
We will act according to the laws of the Ministry of Health and Medical Education and Tabriz University of Medical Sciences

Where to obtain:
Central Library of Tabriz University of Medical Sciences and Faculty of Medicine

How to obtain:
We will act according to the laws of the Ministry of Health and Medical Education and Tabriz University of Medical Sciences

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohamad Mahdi Almiski</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shayan mehr dorm,  eqbal aazar ave, Resalat Street</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5178757395</zip>
        <telephone>+98 41 3441 1230</telephone>
        <email>dr.mahdi.almiski@gmail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohamad Mahdi Almiski</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shayan mehr dorm,  eqbal aazar ave, Resalat Street</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5178757395</zip>
        <telephone>+98 41 3441 1230</telephone>
        <email>dr.mahdi.almiski@gmail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Ability to have a normal vaginal delivery
Existence of labor  pain and the delivery is in  the active phase.
Pregnant mother wants to reduce labor pain it self.
Consent of the patient and her husbend.</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Maternal or spouse dissatisfaction.
Inability of the pregnant to remain motionless while doing work(e.g. Parkinson disease).
Coagulation disorder
Increased intracranial pressure (SOL).
Local infections at the puncture site
History of sensitivity to analgesics and other medication used in this investigation
Acute lesions of the CNS
Hemodynamic Disorders (e.g. hypotension or Hypovolemia).
Cardiovascular Diseases that reduce the cardiac output
Embryonic distress.
GA &lt;37 w, Abnormal fetal presentations, History of C/S - BMI&gt; 40
Abnormal fetal presentations
History of C/S or any surgery on the uterus
History of any surgery on the uterus
BMI&gt; 40</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Epidural analgesia                                                           The neuroaxial  block is performed with epidural needle number 18 G . First, for the  test dose: 3 ml of lidocaine 1.5%, 50 μg of fentanyl and 2.5 mg of bupivacaine  is used. Then as a preservative dose 6 cc / h from this solution is injected through the catheter</i_keyword>
      <i_keyword>Intervention group: combined spinal-epidural analgesia                            First with  a spinal needle 25G, the spinal block with 1.5ml of the same solution is performed and then the epidural block will be performed using the same method of epidural group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Maternal blood pressure. Timepoint: 5 min before performing the analgesia and then 5, 10, 20,40, 60 min after and then  every 30 min until the exit of the fetus. Method of measurement: With the use of a Barometer.</prim_outcome>
      <prim_outcome>Maternal pulse rate. Timepoint: 5 min before performing the analgesia and then 5, 10, 20,40, 60 min after and then  every 30 min until the exit of the fetus. Method of measurement: With the use of a monitor device.</prim_outcome>
      <prim_outcome>Maternal Oxygen Saturation. Timepoint: 5 min before performing the analgesia and then 5, 10, 20,40, 60 min after and then  every 30 min until the exit of the fetus. Method of measurement: With the use of a pulse oximetry.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Apgar score. Timepoint: Minuts 1 and 5. Method of measurement: Calculating.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-06-11</approval_date>
        <contact_name>Ethics committee of Tabriz University of Medical Sciences</contact_name>
        <contact_address>Central Office of the University of Medical Sciences, Golgast Street, Azadi Avenue, Tabriz Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
